glyoxal has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Alouffi, S; Khan, MWA | 1 |
Fujita, Y; Murakami, T; Nakamura, A | 1 |
Bendszus, M; Deshpande, D; Fleming, T; Groener, JB; Hidmark, A; Mendler, M; Muckenthaler, MU; Müller, BP; Nawroth, PP; Pham, M; Reeh, PW; Sauer, SK; Vittas, S | 1 |
3 review(s) available for glyoxal and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy.
Topics: Animals; Biomarkers; Cytokines; Diabetic Neuropathies; Exosomes; Glyoxal; Humans; Inflammation; Lactoylglutathione Lyase; MicroRNAs; Nerve Fibers; Neurons; Polymorphism, Genetic; Pyruvaldehyde; Regenerative Medicine; Toll-Like Receptors | 2021 |
A new paradigm to understand and treat diabetic neuropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glycation End Products, Advanced; Glyoxal; Humans; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2014 |